The California Co-Pay Conundrum

January 2, 2018

TrialCard Addresses AB 265 On October 9, 2017, California Governor Jerry Brown signed AB 265 into law. This landmark piece of legislation modified the California Health and Safety Code to prohibit the “offering” of any discount, product voucher, or other out-of-pocket cost reduction tool by drug manufacturers when there is an FDA-approved therapeutic equivalent. As […]

New Peer-Reviewed Study Finds Illegal Online Pharmacies are Using Twitter to Illegally Sell Percocet®, Fentanyl, Vicodin®, Oxycotin®, and Other Highly Addictive Opiods To U.S. Consumers

October 26, 2017

SAN DIEGO, CA (October 26, 2017) – Results from a new peer-reviewed study to be published in the November issue of American Journal of Public Health (AJPH) found illegal online pharmacies are using Twitter to market and sell Percocet®, Vicodin®, Oxycontin®, hydrocodone, fentanyl and oxycodone and other highly addictive and often deadly controlled substances to U.S. consumers, […]

Bristol-Myers Squibb Employees Ride Across the U.S. to Raise Money to Support Cancer Research by Stand Up To Cancer

September 6, 2017

PRINCETON, N.J.–(BUSINESS WIRE)–The first of seven teams of Bristol-Myers Squibb (NYSE:BMY) employees mounted their bikes in Cannon Beach, OR, today to kick off the 2017 Coast 2 Coast 4 Cancer Ride . Ninety-three novice riders will bike a total of nearly 2,800 miles during the 21-day mission to raise money and awareness for Stand Up […]

Senate Confirms Scott Gottlieb to Head F.D.A.

May 11, 2017

The Senate voted 57 to 42 on Tuesday to confirm Dr. Scott Gottlieb as commissioner of the Food and Drug Administration, where he will be responsible for regulating drug companies to which he has had close ties in recent years.   Dr. Gottlieb, 44, has promised to divest himself from several health care companies and […]

West Virginia Journalist Arrested after asking HHS Secretary Tom Price a question

May 11, 2017

As Health and Human Services Secretary Tom Price walked through a hallway Tuesday in the West Virginia state capitol, veteran reporter Dan Heyman followed alongside him, holding up his phone to Price while attempting to ask him a question. Heyman, a journalist with Public News Service, repeatedly asked the secretary whether domestic violence would be […]

Reactions To The GOP Health Bill: Voices From The States

May 11, 2017

As the American Health Care Act moves toward the Senate, many people around the country are reacting to it. Among them, people with preexisting conditions who worry about losing their coverage. One of the biggest concerns about the House bill is its treatment of preexisting conditions. Several lawmakers were worried it would leave sicker people […]

3 Big Drugmakers That Could Make Billions Under Trump’s Tax Plan

May 4, 2017

President Trump’s much-anticipated tax plan is now on the table — or at least a lot of it is. Treasury Secretary Steven Mnuchin laid out the primary components of the tax proposal on Wednesday. While the changes affect millions of Americans, three big drugmakers in particular stand to make billions of additional dollars if the […]

An Advocacy Rx for Progress in Mental Health

January 31, 2017

Through sustained partnerships between advocacy and industry, the US and Europe can overcome barriers to care. As a source of human suffering, a barrier to workplace productivity, a burden on families and a driver of medical costs, mental illness amounts to an unparalleled public health crisis. Fortunately, there’s an abundance of smart thinking on how to improve the […]

Mental Health: Payer and Advocacy Perspectives in a Time of Policy Uncertainty

January 26, 2017

Heather Gartman discusses patient advocacy in the mental health space, including problem with underfunded research, the numerous stakeholders involved, and ways pharma and these stakeholders can come together to better support this extremely important area of the healthcare ecosystem. Also download our related white paper below, entitled, An Advocacy Rx for Progress in Mental Health.